Please login to the form below

Not currently logged in
Email:
Password:

ViiV

This page shows the latest ViiV news and features for those working in and with pharma, biotech and healthcare.

GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

GSK will also increase prices on around 30 of its drugs, including its Ellipta inhaler, its cancer drug Zejula (niraparib) and HIV products from its ViiV division.

Latest news

More from news
Approximately 36 fully matching, plus 67 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics